<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Acute viral encephalitis in children: Clinical manifestations and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Acute viral encephalitis in children: Clinical manifestations and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Acute viral encephalitis in children: Clinical manifestations and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Hordur S Hardarson, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kevin Messacar, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheldon L Kaplan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Douglas R Nordli, Jr, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 05, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Encephalitis is inflammation of the brain parenchyma, manifest by neurologic dysfunction (eg, altered mental status, behavior, or personality; motor or sensory deficits; speech or movement disorders; seizure) and evidence of central nervous system inflammation (eg, cerebrospinal fluid pleocytosis and/or findings consistent with encephalitis on neuroimaging or electroencephalogram).
        </p>
        <p>
         The clinical manifestations and diagnosis of viral encephalitis in children will be discussed here. The pathogenesis, etiology, treatment, and prevention of viral encephalitis in children are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6043.html" rel="external">
          "Acute viral encephalitis in children: Pathogenesis, epidemiology, and etiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5977.html" rel="external">
          "Acute viral encephalitis in children: Treatment and prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1374040663">
         <span class="h1">
          TERMINOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Central nervous system (CNS) infections are described according to the site of infection:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Encephalitis
         </strong>
         – Encephalitis is defined as inflammation of the brain parenchyma and is manifested by signs of neurologic dysfunction. Characteristic clinical features include altered mental status (decreased level of consciousness, lethargy, personality change, unusual behavior) lasting at least 24 hours, seizures, and/or focal neurologic signs, often accompanied by fever, headache, nausea, and vomiting [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="local">
          'Clinical features'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Meningitis
         </strong>
         – Meningitis is inflammation of the meninges and is typically manifested by fever, headache, nausea, vomiting, photophobia, and stiff neck. (See
         <a class="medical medical_review" href="/z/d/html/5983.html" rel="external">
          "Viral meningitis in children: Clinical features and diagnosis", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rhombencephalitis
         </strong>
         – Rhombencephalitis, or brainstem encephalitis, is characterized by myoclonic jerks, tremor, ataxia, cranial nerve involvement, respiratory abnormalities, shock, and coma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Myelitis
         </strong>
         – Myelitis is inflammation of the spinal cord and is characterized by weakness, paralysis, bowel and/or bladder dysfunction, and changes in tone and reflexes. (See
         <a class="medical medical_review" href="/z/d/html/5093.html" rel="external">
          "Disorders affecting the spinal cord", section on 'Acute viral myelitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Radiculitis
         </strong>
         – Radiculitis is inflammation of the nerve roots and is characterized by weakness, shooting pain, dysesthesia, and diminished reflexes.
        </p>
        <p>
        </p>
        <p>
         Some viruses cause less discrete manifestations CNS infection and are described with broader terms:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Meningoencephalitis
         </strong>
         – Meningoencephalitis refers to CNS infection manifesting signs and symptoms consistent with inflammation of the meninges and brain parenchyma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Encephalomyelitis
         </strong>
         – Encephalomyelitis refers to CNS infection manifesting signs and symptoms consistent with inflammation of the brain parenchyma and spinal cord.
        </p>
        <p>
        </p>
        <p>
         Abnormal brain function distinguishes encephalitis from meningitis. The distinction between these entities is frequently blurred as both may be present concurrently; however, it is important to try to determine the presence of encephalitis because the likely causes may differ somewhat  (
         <a class="graphic graphic_table graphicRef56505" href="/z/d/graphic/56505.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Encephalopathy
         </strong>
         – Encephalopathy is a disruption of brain function in the absence of a direct inflammatory process in brain parenchyma (eg, caused by metabolic disturbance, hypoxia, ischemia, drugs, intoxications, organ dysfunction, systemic infection). This is discussed separately.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         By definition, encephalitis is manifested by signs of neurologic dysfunction, which can be variable. Common presenting symptoms and signs include [
         <a href="#rid2">
          2,3
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fever (75 to 80 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizures (50 to 75 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Irritability or unusual behavior (55 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Focal neurologic signs (eg, cranial nerve palsies, abnormal movements, weakness; 50 to 60 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased consciousness (45 to 55 percent)
        </p>
        <p>
        </p>
        <p>
         Clinical manifestations may vary depending upon the patient's age and immune status, causative virus, and affected region(s) of the brain [
         <a href="#rid3">
          3,4
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neonates and young infants
         </strong>
         – As with other infections in neonates (0 to 28 days) and young infants, the presentation of encephalitis can be nonspecific. Encephalitis should be considered in a neonate or young infant who has fever, seizure, poor feeding, irritability, or lethargy. Decreased perfusion may occur in infants with encephalitis and concomitant disseminated viral infection (eg, herpes simplex virus [HSV], enteroviruses, and parechoviruses). Fever is a variable finding. Neonates who have viral illness, especially HSV and enterovirus, are at risk for severe central nervous system (CNS) and systemic illness. (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Children and adolescents
         </strong>
         – In older children and adolescents, encephalitis can present with fever, psychiatric symptoms, emotional lability, movement disorder, ataxia, seizures, stupor, lethargy, coma, or localized neurologic changes (eg, paresis, cranial nerve defect) [
         <a href="#rid5">
          5,6
         </a>
         ]. In severe cases, status epilepticus, cerebral edema, syndrome of inappropriate antidiuretic hormone secretion (SIADH), and/or cardiorespiratory failure may occur.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1506860244">
         <span class="h1">
          EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H3295463106">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         Encephalitis is an acute, life-threatening emergency, and a systematic approach is necessary for prompt recognition and appropriate management  (
         <a class="graphic graphic_table graphicRef51779" href="/z/d/graphic/51779.html" rel="external">
          table 2
         </a>
         ). The goals of the evaluation are to define the clinical syndrome (eg, acute encephalitis, postinfectious encephalitis, autoimmune encephalitis, meningitis, toxic or metabolic encephalopathy) and to identify a specific etiology [
         <a href="#rid7">
          7
         </a>
         ]. Identification of a specific etiology can inform treatment decisions  (
         <a class="graphic graphic_table graphicRef62512" href="/z/d/graphic/62512.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_table graphicRef68501" href="/z/d/graphic/68501.html" rel="external">
          table 4
         </a>
         ) and may be useful for prognosis, potential prophylaxis, and public health interventions [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5977.html" rel="external">
          "Acute viral encephalitis in children: Treatment and prevention", section on 'Empiric antimicrobial therapy'
         </a>
         .)
        </p>
        <p>
         Early identification of the underlying cause can be crucial for patient management and prognosis. The approach outlined below is generally consistent with the diagnostic algorithm suggested by the International Encephalitis Consortium [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         The initial step in the evaluation of the child with altered brain function begins with assessment of the airway, breathing, and circulation. The first priorities are stabilization of cardiorespiratory status and management of seizures. (See
         <a class="medical medical_review" href="/z/d/html/6393.html" rel="external">
          "Initial assessment and stabilization of children with respiratory or circulatory compromise"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6192.html" rel="external">
          "Management of convulsive status epilepticus in children", section on 'Emergency antiseizure treatment'
         </a>
         .)
        </p>
        <p>
         After the child is stabilized, a thorough history, physical examination, initial laboratory tests, lumbar puncture (LP), and neuroimaging are performed [
         <a href="#rid7">
          7
         </a>
         ]. Electroencephalography (EEG) should be performed as soon as is feasible. In cases with a clinically suspected focal lesion of the central nervous system (CNS), neuroimaging should be performed before LP if time allows. Epidemiologic and historical clues  (
         <a class="graphic graphic_table graphicRef57122" href="/z/d/graphic/57122.html" rel="external">
          table 5
         </a>
         and
         <a class="graphic graphic_table graphicRef73833" href="/z/d/graphic/73833.html" rel="external">
          table 6
         </a>
         ), physical examination findings  (
         <a class="graphic graphic_table graphicRef71744" href="/z/d/graphic/71744.html" rel="external">
          table 7
         </a>
         ), and data from the initial laboratory and imaging tests may help direct additional evaluation and/or therapy.
        </p>
        <p class="headingAnchor" id="H529537774">
         <span class="h2">
          History
         </span>
         <span class="headingEndMark">
          —
         </span>
         The history may provide clues to a particular viral etiology, as summarized in the tables  (
         <a class="graphic graphic_table graphicRef57122" href="/z/d/graphic/57122.html" rel="external">
          table 5
         </a>
         and
         <a class="graphic graphic_table graphicRef73833" href="/z/d/graphic/73833.html" rel="external">
          table 6
         </a>
         ). When evaluating a patient with suspected encephalitis, it is important to ask specific questions regarding travel and exposures (eg, animals, insects, water, toxins, etc), particularly within the two to three weeks before onset. Immunizations and immune status should also be reviewed [
         <a href="#rid4">
          4,7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2102977959">
         <span class="h2">
          Physical examination
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neurologic examination
         </strong>
         – A careful neurologic examination should be performed, including the following (see
         <a class="medical medical_review" href="/z/d/html/15360.html" rel="external">
          "Detailed neurologic assessment of infants and children"
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mental status examination
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Assessment of the motor, sensory, cranial nerve, cerebellar, and reflex function
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fundoscopic examination
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Glasgow coma scale score  (
         <a class="graphic graphic_table graphicRef59662" href="/z/d/graphic/59662.html" rel="external">
          table 8
         </a>
         ), which quantifies the level of consciousness and can be used to monitor neurologic progression, although it has not specifically been validated in patients with encephalitis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Skin examination
         </strong>
         – Dermatologic findings may point to a specific etiology  (
         <a class="graphic graphic_table graphicRef71744" href="/z/d/graphic/71744.html" rel="external">
          table 7
         </a>
         ). Examples include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vesicular rash in neonates with CNS herpes simplex virus (HSV) disease  (
         <a class="graphic graphic_picture graphicRef56041 graphicRef75059 graphicRef78598" href="/z/d/graphic/56041.html" rel="external">
          picture 1A-C
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Neonatal HSV'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Maculopapular rash in West Nile virus disease  (
         <a class="graphic graphic_picture graphicRef54623" href="/z/d/graphic/54623.html" rel="external">
          picture 2
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/1273.html" rel="external">
          "Clinical manifestations and diagnosis of West Nile virus infection", section on 'Clinical manifestations'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Characteristic lesions of hand, foot, and mouth disease (enteroviruses, especially EV-A71, CVA16, and CVA6)  (
         <a class="graphic graphic_picture graphicRef52800 graphicRef58566 graphicRef71314 graphicRef53423" href="/z/d/graphic/52800.html" rel="external">
          picture 3A-D
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/96219.html" rel="external">
          "Hand, foot, and mouth disease and herpangina"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The rash of Rocky Mountain spotted fever  (
         <a class="graphic graphic_picture graphicRef58061" href="/z/d/graphic/58061.html" rel="external">
          picture 4
         </a>
         ), which typically does not appear until several days after the onset of fever (see
         <a class="medical medical_review" href="/z/d/html/7904.html" rel="external">
          "Clinical manifestations and diagnosis of Rocky Mountain spotted fever"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1399016853">
         <span class="h2">
          Laboratory evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laboratory studies are performed to support the clinical diagnosis of encephalitis and establish an etiology  (
         <a class="graphic graphic_table graphicRef62512" href="/z/d/graphic/62512.html" rel="external">
          table 3
         </a>
         ), assess for other conditions in the differential diagnosis  (
         <a class="graphic graphic_table graphicRef68501" href="/z/d/graphic/68501.html" rel="external">
          table 4
         </a>
         ), and look for potential complications (eg, syndrome of inappropriate antidiuretic hormone secretion [SIADH]).
        </p>
        <p class="headingAnchor" id="H4027879692">
         <span class="h3">
          Routine blood tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laboratory tests that should be routinely performed in all patients with suspected encephalitis include  (
         <a class="graphic graphic_table graphicRef63632" href="/z/d/graphic/63632.html" rel="external">
          table 9
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complete blood count with differential count and platelets
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum electrolytes, glucose, blood urea nitrogen, and creatinine
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Liver function tests (alanine aminotransferase, aspartate aminotransferase, total and direct bilirubin)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Coagulation studies
        </p>
        <p>
        </p>
        <p>
         Laboratory findings that may provide clues to the etiology include the following [
         <a href="#rid7">
          7
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neutropenia – Colorado tick fever, ehrlichiosis, neonatal HSV, measles, rickettsiae, rubella
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thrombocytopenia – Ehrlichiosis, rickettsiae, neonatal HSV [
         <a href="#rid8">
          8
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eosinophilia –
         <em>
          Toxocara
         </em>
         ,
         <em>
          Trichinella
         </em>
         , and other parasites
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hyponatremia/SIADH – Rickettsiae, Eastern equine encephalitis virus, St. Louis encephalitis virus, HSV,
         <em>
          Mycobacterium
         </em>
         <em>
          tuberculosis
         </em>
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3987332664">
         <span class="h3">
          Cerebrospinal fluid analysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         LP should be performed in all patients with suspected encephalitis unless there are contraindications (eg, coagulopathy, suspected or known mass lesion) [
         <a href="#rid5">
          5
         </a>
         ]. If there are signs of impending herniation (asymmetric pupils, severe obtundation, decorticate or decerebrate posturing, Cheyne-Stokes breathing), neuroimaging is required before LP to exclude contraindications (mass lesion, midline shift). (See
         <a class="local">
          'Neuroimaging'
         </a>
         below.)
        </p>
        <p>
         Samples of cerebrospinal fluid (CSF) should be sent for cell count and differential, glucose, protein, Gram stain, bacterial culture, HSV polymerase chain reaction (PCR), parechovirus PCR, and enterovirus PCR; additional tests should be done as indicated by epidemiology and clinical findings [
         <a href="#rid6">
          6,7
         </a>
         ]. (See
         <a class="local">
          'Identifying the viral pathogen'
         </a>
         below.)
        </p>
        <p>
         The CSF indices in viral encephalitis are similar to those in viral meningitis and meningoencephalitis; however, CSF indices may overlap with those of bacterial meningitis in some cases  (
         <a class="graphic graphic_table graphicRef76324" href="/z/d/graphic/76324.html" rel="external">
          table 10
         </a>
         ). Characteristic findings include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         CSF pleocytosis – CSF pleocytosis is present in 60 to 80 percent of children with encephalitis [
         <a href="#rid3">
          3,9-11
         </a>
         ]. The CSF white blood cell (WBC) count typically ranges from 0 to 500 cells/microL, with a lymphocytic predominance; however, a predominance of neutrophils can be seen during the first 24 to 48 hours of infection. The absence of pleocytosis does not exclude encephalitis, and a normal CSF WBC count can be seen early in the course and in infants with encephalitis, particularly with parechovirus and enterovirus infections [
         <a href="#rid12">
          12,13
         </a>
         ]. In addition, immune-compromised patients may not mount a CSF pleocytosis [
         <a href="#rid14">
          14,15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Red blood cells – Red blood cells are usually absent (except in traumatic tap). The presence of RBCs in a nontraumatic tap is more indicative of the disease process (hemorrhagic or necrotizing encephalitis) rather than a specific etiology per se. Infectious etiologies that may present with hemorrhagic or necrotizing encephalitis include HSV, La Crosse virus, Eastern equine encephalitis, and amebic encephalitis; however, there is considerable variation in the presentation of these encephalitides [
         <a href="#rid16">
          16,17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8278.html" rel="external">
          "Herpes simplex virus type 1 encephalitis", section on 'Laboratory abnormalities'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5687.html" rel="external">
          "Free-living amebas and Prototheca", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protein – CSF protein may be normal or moderately elevated (generally &lt;150 mg/dL).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glucose – Glucose is usually normal (ie, &gt;50 percent of blood glucose value). Moderate reduction in glucose can be seen with HSV and mumps; marked hypoglycorrhachia (ie, CSF glucose &lt;10 mg/dL) can be seen in bacterial meningitis, including tuberculous (TB), but is only rarely reported with viral infections of the CNS.
        </p>
        <p>
        </p>
        <p>
         In approximately 10 to 15 percent of cases, initial CSF findings are normal [
         <a href="#rid3">
          3,9,11,18
         </a>
         ].
        </p>
        <p>
         In a study of &gt;1500 cases of encephalitis, there was a wide range of CSF WBC counts and protein levels [
         <a href="#rid11">
          11
         </a>
         ]. Patients with infectious encephalitis had higher CSF WBC compared with patients with noninfectious encephalitis (median CSF WBC 54 versus 10 cells/microL), but protein levels were similar (median level 71 versus 67 mg/dL). Among patients with viral encephalitis, 83 percent had CSF pleocytosis (defined as WBC count ≥6 cells/microL) and 68 percent had elevated CSF protein (defined as protein level &gt;45 mg/dL).
        </p>
        <p class="headingAnchor" id="H1641232462">
         <span class="h3">
          Evaluation for other causes of encephalopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Additional testing is performed to exclude other causes of encephalopathy (eg, bacterial sepsis or meningitis, metabolic disorders, drugs and toxins, autoimmune encephalitis). This includes (see
         <a class="local">
          'Differential diagnosis'
         </a>
         below):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood culture
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         CSF Gram stain, acid fast stain, and culture
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urine and serum toxicology screening (see
         <a class="medical medical_review" href="/z/d/html/6496.html" rel="external">
          "Approach to the child with occult toxic exposure"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic studies (serum ammonia, lactate, and blood pH) (see
         <a class="medical medical_review" href="/z/d/html/17216.html" rel="external">
          "Inborn errors of metabolism: Identifying the specific disorder"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anti-N-methyl-D-aspartate receptor (NMDAR), voltage-gated potassium channel (VGKC), and antimyelin oligodendrocyte glycoprotein (MOG) antibodies, if clinically indicated (see
         <a class="medical medical_review" href="/z/d/html/15759.html" rel="external">
          "Autoimmune (including paraneoplastic) encephalitis: Clinical features and diagnosis", section on 'Antibody testing'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2022125840">
         <span class="h3">
          Identifying the viral pathogen
         </span>
         <span class="headingEndMark">
          —
         </span>
         Testing for specific pathogens is directed by the clinical findings, initial laboratory findings, and other epidemiologic circumstances (eg, time of year, geographic locale, exposures).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          CSF studies
         </strong>
         – Tests of the CSF that can help to establish an infectious etiology for encephalitis include PCR and antibody testing [
         <a href="#rid7">
          7
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Multiplex PCR testing
         </strong>
         – Multiplex nucleic acid amplification tests are now available that test for multiple bacterial and viral pathogens simultaneously in a single CSF sample (eg, FilmArray meningitis/encephalitis panel [BioFire]) [
         <a href="#rid19">
          19-21
         </a>
         ]. Where available, these PCR panels can be helpful in evaluating a child with suspected encephalitis. The FilmArray panel targets 14 pathogens: cytomegalovirus (CMV), enteroviruses, HSV 1 and 2, human herpesvirus 6 (HHV-6), parechoviruses, varicella-zoster virus (VZV),
         <em>
          Escherichia
         </em>
         <em>
          coli
         </em>
         K1,
         <em>
          Haemophilus
         </em>
         <em>
          influenzae
         </em>
         ,
         <em>
          Listeria
         </em>
         <em>
          monocytogenes
         </em>
         ,
         <em>
          Neisseria
         </em>
         <em>
          meningitidis
         </em>
         ,
         <em>
          Streptococcus
         </em>
         <em>
          agalactiae
         </em>
         ,
         <em>
          Streptococcus
         </em>
         <em>
          pneumoniae
         </em>
         , and
         <em>
          Cryptococcus
         </em>
         [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Multiplex PCR tests are highly sensitive and specific, though false-positive and false-negative results can occur. If a multiplex panel is performed, it should be used in conjunction with standard microbiologic tests (eg, cultures of CSF and blood). Multiplex panels do not detect all causes of CNS infection, nor do they provide any information on antimicrobial susceptibility.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Multiplex PCR testing is less sensitive for HSV-1 and HSV-2 than standard HSV PCR assays, and, therefore, it may be necessary to test specifically for HSV when clinical suspicion for HSV infection is high [
         <a href="#rid20">
          20
         </a>
         ]. If HSV infection is suspected in an infant &lt;6 weeks old, other specimens in addition to CSF should be tested (eg, surface cultures and blood or plasma HSV PCR). The evaluation of suspected neonatal HSV infection is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Evaluation and diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Individual PCR tests
         </strong>
         – If multiplex testing is not available, enterovirus, parechovirus, and HSV CSF PCR testing should be performed [
         <a href="#rid7">
          7
         </a>
         ]. These tests are helpful when positive, but negative tests do not necessarily exclude the pathogen. CSF enterovirus PCR does not permit identification of the enterovirus serotype. Enterovirus A71, an important cause of encephalitis in young children, is rarely detected by CSF PCR.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          CSF antibody testing
         </strong>
         – The detection of virus-specific immunoglobulin M (IgM) in the CSF usually indicates CNS disease because IgM antibodies do not readily cross the blood-brain barrier.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Viral culture
         </strong>
         – CSF viral cultures are
         <strong>
          not
         </strong>
         routinely recommended [
         <a href="#rid7">
          7,23
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Testing of sites outside of the CNS
         </strong>
         – When the pathogen is identified from an anatomic site other than the CNS (eg, respiratory tract, skin, stool), the results must be interpreted in conjunction with epidemiologic and clinical findings and other diagnostic studies  (
         <a class="graphic graphic_table graphicRef57122" href="/z/d/graphic/57122.html" rel="external">
          table 5
         </a>
         and
         <a class="graphic graphic_table graphicRef73833" href="/z/d/graphic/73833.html" rel="external">
          table 6
         </a>
         and
         <a class="graphic graphic_table graphicRef71744" href="/z/d/graphic/71744.html" rel="external">
          table 7
         </a>
         ) [
         <a href="#rid7">
          7
         </a>
         ]. The pathogen detected may play a role in the CNS manifestations (but not necessarily by direct invasion) or may be present but unrelated to encephalitis (eg, rhinoviruses in nasal secretions, Epstein-Barr virus [EBV], or
         <em>
          Mycoplasma
         </em>
         <em>
          pneumoniae
         </em>
         DNA detected in throat swabs) [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antibody titers
         </strong>
         – Acute and convalescent antibody titers may be helpful if cultures and PCR have not established a diagnosis and the patient remains ill. Detection of antibodies in acute serum may be helpful in identifying some pathogens (arboviruses, HIV, rabies) and may be used as evidence of causation if the infection is rare or highly fatal (eg, rabies, Eastern equine encephalitis) [
         <a href="#rid6">
          6,7,24
         </a>
         ]. The presence of antibodies to an enterovirus or parechovirus at a single time point does not provide sufficient proof of recent infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Brain biopsy
         </strong>
         – Brain biopsy can be considered if the etiology remains uncertain after extensive noninvasive testing in a patient with a severe and/or progressive disease course despite empiric therapy [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         It may be helpful to have samples of CSF and serum frozen to allow for further testing later if the diagnosis is not reached initially.
        </p>
        <p class="headingAnchor" id="H1911189264">
         <span class="h3">
          Approach for specific pathogens
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnostic approach for specific pathogens is as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Enteroviruses
         </strong>
         – Enteroviral CNS infections are diagnosed by detection of the virus in the CSF using PCR. Throat and rectal swabs can also be tested with PCR. In a child with clinical findings consistent with encephalitis, detection of enterovirus in a non-CSF sample suggests enterovirus as the etiology, though it is not definitive. This is particularly true of rectal swabs and fecal specimens since fecal shedding often continues for many weeks after an asymptomatic infection. (See
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Laboratory diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          HSV
         </strong>
         – HSV encephalitis is diagnosed by detection of the virus in the CSF using PCR. If clinical suspicion for HSV encephalitis is high and initial CSF HSV PCR performed early in the course is negative, testing can be repeated (ie, with repeat LP) three to seven days later [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8286.html" rel="external">
          "PCR testing for the diagnosis of herpes simplex virus in patients with encephalitis or meningitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If HSV infection is suspected in an infant &lt;6 weeks old, other specimens in addition to CSF should be tested (eg, surface cultures and blood or plasma HSV PCR). The evaluation of suspected neonatal HSV infection is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Evaluation and diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other herpesviruses
         </strong>
         (including HHV-6, CMV, VZV, EBV) – These can be diagnosed with CSF PCR testing. In the case of VZV, direct immunofluorescence assay of skin lesions (if present) may be helpful. Note that for EBV, CMV, VZV, and HHV-6, detection of the DNA in the CSF by PCR does not absolutely indicate CNS infection, because latently infected cells, chromosomal integration, or shedding of DNA into the CSF can cause a clinical false-positive result [
         <a href="#rid1">
          1,7
         </a>
         ]. Positive herpesvirus PCRs in CSF should be followed by confirmatory testing. For EBV, CMV, and VZV, this involves measuring serum antibody titers (for HHV-6, measuring quantitative DNA PCR in whole blood to exclude HHV-6 chromosomal integration) [
         <a href="#rid1">
          1,25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Arboviruses
         </strong>
         (LaCrosse virus, West Nile virus, St. Louis encephalitis virus, Eastern and Western equine encephalitis virus, Japanese encephalitis virus) – These are diagnosed with appropriate serology and PCR testing. (See
         <a class="medical medical_review" href="/z/d/html/1293.html" rel="external">
          "Arthropod-borne encephalitides"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Respiratory viruses
         </strong>
         (including influenza, adenovirus, human metapneumovirus, and respiratory syncytial virus) – These can be identified with respiratory viral panel (PCR) and viral culture of respiratory secretions/nasopharynx; however, positive results do not necessarily indicate direct CNS infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          HIV
         </strong>
         . (See
         <a class="medical medical_review" href="/z/d/html/6006.html" rel="external">
          "Diagnostic testing for HIV infection in infants and children younger than 18 months"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3736.html" rel="external">
          "Screening and diagnostic testing for HIV infection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonviral pathogens
         </strong>
         – Appropriate testing is discussed in separate topic reviews:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          M
         </em>
         .
         <em>
          pneumoniae
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/6070.html" rel="external">
          "
          <i>
           Mycoplasma pneumoniae
          </i>
          infection in children", section on 'Diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          L
         </em>
         .
         <em>
          monocytogenes
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          M
         </em>
         .
         <em>
          tuberculosis
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/8009.html" rel="external">
          "Central nervous system tuberculosis: An overview"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Bartonella
         </em>
         <em>
          henselae
         </em>
         (cat scratch disease) (see
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease", section on 'Diagnostic tests'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Borrelia
         </em>
         <em>
          burgdorferi
         </em>
         and other
         <em>
          Borrelia
         </em>
         species (Lyme disease) (see
         <a class="medical medical_review" href="/z/d/html/15247.html" rel="external">
          "Nervous system Lyme disease", section on 'Evaluation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Rickettsia
         </em>
         <em>
          rickettsii
         </em>
         (Rocky Mountain spotted fever) (see
         <a class="medical medical_review" href="/z/d/html/7904.html" rel="external">
          "Clinical manifestations and diagnosis of Rocky Mountain spotted fever", section on 'Diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         Evaluation for additional pathogens may be warranted in immunocompromised patients  (
         <a class="graphic graphic_table graphicRef63632" href="/z/d/graphic/63632.html" rel="external">
          table 9
         </a>
         ).
        </p>
        <p>
         The United States Centers for Disease Control and Prevention (CDC) should be notified when certain pathogens are isolated from patients in the United States. The list of notifiable conditions is available on the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fndc.services.cdc.gov%2Fsearch-results-year%2F&amp;token=Y5VuphMrv4G%2FXx7ShvqbzZt2h4UfR3BqYPjLxCVOdtdLHw2msnTt4ES55D712B17C24fEmcoLwrQQtRxH%2FCYCA%3D%3D&amp;TOPIC_ID=6042" target="_blank">
          CDC website
         </a>
         .
        </p>
        <p class="headingAnchor" id="H952132703">
         <span class="h2">
          Neuroimaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients with suspected encephalitis should undergo neuroimaging [
         <a href="#rid1">
          1,5-7
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Timing
         </strong>
         – If there are signs of impending herniation (asymmetric pupils, severe obtundation, decorticate or decerebrate posturing, Cheyne-Stokes breathing), neuroimaging should be performed urgently before performing lumbar puncture. Computed tomography [CT] is typically performed as the initial study in this setting because it is faster and generally does not require sedation/anesthesia. Children with encephalitis who undergo initial imaging with CT should subsequently have magnetic resonance imaging (MRI) performed, as discussed below.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For children without clinical concern for impending herniation, MRI can be performed after completing the initial evaluation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preferred modality
         </strong>
         – MRI is the neuroimaging modality of choice because it is more sensitive and specific for encephalitis than is CT. In one study, 30 percent of patients with normal initial CT were subsequently found to have abnormalities on MRI [
         <a href="#rid26">
          26
         </a>
         ]. If timely MRI is unavailable or not feasible, CT (with and without contrast enhancement) is an acceptable alternative, particularly in the initial evaluation [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="local">
          'Cerebrospinal fluid analysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition to standard T1- and T2-weighted images, diffusion-weighted imaging appears to increase the sensitivity of MRI, particularly early in the course [
         <a href="#rid27">
          27-30
         </a>
         ]. On rare occasions, findings on MRI may lead to presumptive diagnosis of HSV encephalitis despite an initial negative CSF HSV PCR [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          MRI findings
         </strong>
         – Abnormal neuroradiologic findings are seen in 60 to 70 percent of patients with encephalitis; findings are present at the time of presentation in 30 to 50 percent [
         <a href="#rid2">
          2,26
         </a>
         ]. Findings may include brain edema and inflammation of the cerebral cortex, gray-white matter junction, thalamus, or basal ganglia [
         <a href="#rid6">
          6,31
         </a>
         ]. Meningeal enhancement may be seen in children with meningoencephalitis. Children with HSV encephalitis may have hemorrhagic findings [
         <a href="#rid32">
          32-34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Findings according to viral etiology
         </strong>
         – MRI findings vary somewhat depending on the viral etiology. However, with the exception of temporal lobe localization in HSV encephalitis, most findings are not highly sensitive or specific for a particular pathogen. Typical findings include [
         <a href="#rid6">
          6,7,11,31
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         HSV – Temporal lobe localization  (
         <a class="graphic graphic_diagnosticimage graphicRef80797" href="/z/d/graphic/80797.html" rel="external">
          image 1
         </a>
         ); temporal localization also may occur with other herpes viruses and syphilis. (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Brain imaging'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8278.html" rel="external">
          "Herpes simplex virus type 1 encephalitis", section on 'Imaging studies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         West Nile virus and Eastern equine encephalitis virus – Lesions in the thalamus, basal ganglia, and midbrain that are of mixed intensity or hypodense on T1 and hyperdense on T2 and fluid-attenuated inversion recovery images. (See
         <a class="medical medical_review" href="/z/d/html/1293.html" rel="external">
          "Arthropod-borne encephalitides"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Enterovirus A71 encephalitis – Hyperintense T2 and fluid-attenuated inversion recovery lesions in the midbrain, pons, and medulla. (See
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Respiratory virus encephalitis (eg, influenza, parainfluenza, adenovirus, respiratory syncytial virus) – Abnormalities in the thalamus or basal ganglia. (See
         <a class="medical medical_review" href="/z/d/html/5973.html" rel="external">
          "Seasonal influenza in children: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Findings that suggest a nonviral etiology
         </strong>
         – Neuroimaging also may detect other conditions that are in the differential diagnosis  (
         <a class="graphic graphic_table graphicRef68501" href="/z/d/graphic/68501.html" rel="external">
          table 4
         </a>
         ) (see
         <a class="local">
          'Differential diagnosis'
         </a>
         below):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Acute disseminated encephalomyelitis – Deep and subcortical white matter lesions are typically multiple and bilateral but may be asymmetric  (
         <a class="graphic graphic_diagnosticimage graphicRef76694" href="/z/d/graphic/76694.html" rel="external">
          image 2
         </a>
         ). Brainstem and spinal cord abnormalities are common. Gray matter lesions may be observed in the thalami and basal ganglia. (See
         <a class="medical medical_review" href="/z/d/html/6184.html" rel="external">
          "Acute disseminated encephalomyelitis (ADEM) in children: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Head trauma or intracranial hemorrhage – In most cases, CT is the preferred imaging modality for the initial evaluation of suspected head trauma or intracranial hemorrhage  (
         <a class="graphic graphic_diagnosticimage graphicRef108187" href="/z/d/graphic/108187.html" rel="external">
          image 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6566.html" rel="external">
          "Severe traumatic brain injury (TBI) in children: Initial evaluation and management", section on 'Imaging'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/107995.html" rel="external">
          "Hemorrhagic stroke in children", section on 'Urgent neuroimaging'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         CNS tumor. (See
         <a class="medical medical_review" href="/z/d/html/6250.html" rel="external">
          "Clinical manifestations and diagnosis of central nervous system tumors in children", section on 'Neuroimaging'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Congenital infection (eg, toxoplasmosis, CMV) – Intracranial calcifications (better detected with CT)  (
         <a class="graphic graphic_diagnosticimage graphicRef69239" href="/z/d/graphic/69239.html" rel="external">
          image 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6011.html" rel="external">
          "Overview of TORCH infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <em>
          Balamuthia
         </em>
         <em>
          mandrillaris
         </em>
         and
         <em>
          Acanthamoeba
         </em>
         species – Space-occupying lesions or unifocal or multifocal ring-enhancing lesions are seen with these amoebae  (
         <a class="graphic graphic_diagnosticimage graphicRef85823" href="/z/d/graphic/85823.html" rel="external">
          image 5
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5687.html" rel="external">
          "Free-living amebas and Prototheca", section on 'Balamuthia mandrillaris'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3249222029">
         <span class="h2">
          Electroencephalogram
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with suspected encephalitis should undergo EEG as soon as is feasible. For practical reasons, the EEG is typically performed after the initial evaluation in the emergency department or other acute care settings [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         EEG may help to differentiate encephalitis from nonconvulsive seizure activity (ie partial complex seizures, absence seizures). Continuous EEG may be helpful in documenting or excluding seizures, nonconvulsive seizure activity, and seizure-mimic if routine EEG is negative or inconclusive [
         <a href="#rid35">
          35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6222.html" rel="external">
          "Clinical features and complications of status epilepticus in children"
         </a>
         .)
        </p>
        <p>
         EEG is abnormal in 87 to 96 percent of children with encephalitis; most findings are nonspecific [
         <a href="#rid2">
          2,9,36
         </a>
         ]. EEG findings range from generalized slowing to patterns characteristic of specific etiologies (eg, lateralized periodic discharges or temporal focus of
         <em>
          Herpesviridae
         </em>
         encephalitis) [
         <a href="#rid1">
          1,11,37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8278.html" rel="external">
          "Herpes simplex virus type 1 encephalitis", section on 'Electroencephalogram'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3021.html" rel="external">
          "Measles: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Subacute sclerosing panencephalitis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2398079800">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Encephalitis is largely a clinical diagnosis, based upon the following criteria [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Altered mental status (ie, decreased or altered level of consciousness, lethargy, or personality/behavior change) lasting ≥24 hours with no alternative cause identified,
         <strong>
          plus
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         ≥2 of the following for a "possible" diagnosis or ≥3 of the following for a "probable" diagnosis:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Documented fever ≥38°C (100.4°F) within 72 hours (before or after) presentation
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Generalized or partial seizures not fully attributable to preexisting seizure disorder
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         New-onset focal neurologic findings
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cerebrospinal fluid (CSF) white blood cell (WBC) count ≥5 cells/microL
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abnormality of brain parenchyma on neuroimaging suggestive of encephalitis that is new or appears to have acute onset (see
         <a class="local">
          'Neuroimaging'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abnormality on electroencephalography (EEG) that is consistent with encephalitis and not attributable to another cause (see
         <a class="local">
          'Electroencephalogram'
         </a>
         above)
        </p>
        <p>
        </p>
        <p>
         Identification of a pathogen known to cause encephalitis confirms the clinical diagnosis of viral encephalitis; however, it is important to recognize that in most cases, a specific etiology is not identified despite extensive testing [
         <a href="#rid1">
          1
         </a>
         ]. In these cases, a presumptive diagnosis is made on the basis of the clinical findings and exclusion of other causes of encephalopathy. (See
         <a class="local">
          'Identifying the viral pathogen'
         </a>
         above and
         <a class="local">
          'Differential diagnosis'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6043.html" rel="external">
          "Acute viral encephalitis in children: Pathogenesis, epidemiology, and etiology", section on 'Etiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are numerous mimics of viral encephalitis  (
         <a class="graphic graphic_table graphicRef68501" href="/z/d/graphic/68501.html" rel="external">
          table 4
         </a>
         ). Many of these conditions require specific therapy, and prompt initiation of therapy may improve outcome. Information from the history, examination, laboratory, and radiologic evaluation can help distinguish between viral encephalitis and other conditions in the differential diagnosis. (See
         <a class="local">
          'Evaluation'
         </a>
         above.)
        </p>
        <p>
         In a prospective multicenter study of 526 children ≤14 years old who underwent evaluation for suspected encephalitis from 2013 to 2016, 45 percent of patients were ultimately diagnosed with other conditions [
         <a href="#rid3">
          3
         </a>
         ]. The most common alternate diagnoses were bacterial or viral meningitis. Other diagnoses included tuberculous (TB) meningitis, disseminated neonatal herpes simplex virus (HSV), acute cerebellar ataxia, stroke, structural brain disease, epilepsy, genetic/metabolic disorders, Guillain-Barre syndrome, psychiatric disorders, medication side effect/overdose, and other miscellaneous forms of encephalopathy.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Other infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bacterial, parasitic, fungal, and rickettsial infections of the central nervous system (CNS) can mimic viral encephalitis  (
         <a class="graphic graphic_table graphicRef62512" href="/z/d/graphic/62512.html" rel="external">
          table 3
         </a>
         ). These infections usually are diagnosed through culture, serology, nucleic acid amplification tests (eg, polymerase chain reaction [PCR]), examination of blood smears, and other microbiologic methods [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="local">
          'Laboratory evaluation'
         </a>
         above.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bacterial meningitis
         </strong>
         – The clinical manifestations and cerebrospinal fluid (CSF) indices of bacterial meningitis and viral encephalitis may overlap in some cases  (
         <a class="graphic graphic_table graphicRef76324" href="/z/d/graphic/76324.html" rel="external">
          table 10
         </a>
         ). In such cases, the diagnosis of bacterial meningitis is confirmed by identification of a bacterial pathogen from the CSF (by culture or other diagnostic techniques) or isolation of bacteria from the blood in a patient with CSF pleocytosis. (See
         <a class="medical medical_review" href="/z/d/html/5968.html" rel="external">
          "Bacterial meningitis in children older than one month: Clinical features and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          TB meningitis
         </strong>
         – CNS infection with
         <em>
          M
         </em>
         .
         <em>
          tuberculosis
         </em>
         can present with similar findings and can have CSF findings similar to viral encephalitis [
         <a href="#rid11">
          11
         </a>
         ]. TB meningitis should be suspected in patients with relevant epidemiologic factors (history of prior TB infection or disease, known or possible TB exposure, and/or past or present residence in or travel to an area where TB is endemic). In addition, extremely low glucose (&lt;10 mg/dL) and elevated protein (&gt;200 mg/dL) are characteristic of TB meningitis and rarely occur with viral encephalitis. The diagnosis of TB meningitis is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/128000.html" rel="external">
          "Tuberculous meningitis: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8007.html" rel="external">
          "Tuberculosis disease in children: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Free-living amebae
         </strong>
         – Primary amebic meningoencephalitis caused by
         <em>
          Naegleria
         </em>
         <em>
          fowleri
         </em>
         and granulomatous amebic meningoencephalitis caused by
         <em>
          Acanthamoeba
         </em>
         spp or
         <em>
          Balamuthia
         </em>
         <em>
          mandrillaris
         </em>
         are CNS infections caused by free-living amebae. These infections are rare and almost always fatal. (See
         <a class="medical medical_review" href="/z/d/html/5687.html" rel="external">
          "Free-living amebas and Prototheca"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Autoimmune and postinfectious causes
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Autoimmune encephalitis
         </strong>
         – Autoimmune encephalitis due to antibodies against neuronal proteins (eg, N-methyl-D-aspartate receptor [NMDAR], voltage-gated potassium channel [VGKC], myelin oligodendrocyte glycoprotein [MOG], and others) are increasingly recognized as causes of encephalitis in children  (
         <a class="graphic graphic_table graphicRef135170" href="/z/d/graphic/135170.html" rel="external">
          table 11
         </a>
         ) [
         <a href="#rid36">
          36,38-41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15759.html" rel="external">
          "Autoimmune (including paraneoplastic) encephalitis: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a retrospective single-center cohort of 164 children with acute encephalitis, autoimmune encephalitis was the identified etiology in 13 percent and was the second most common cause of noninfectious encephalitis (after acute disseminated encephalomyelitis) [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Anti-NMDAR encephalitis should be considered in children and adolescents who present with psychiatric symptoms, abnormal movements, seizure, autonomic instability, and hypoventilation [
         <a href="#rid40">
          40,41
         </a>
         ]. It is important to identify anti-NMDAR encephalitis because it may be associated with tumors (eg, ovarian teratomas) and often responds to specific therapeutic interventions. (See
         <a class="medical medical_review" href="/z/d/html/15759.html" rel="external">
          "Autoimmune (including paraneoplastic) encephalitis: Clinical features and diagnosis", section on 'Anti-NMDA receptor encephalitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute disseminated encephalomyelitis (ADEM)
         </strong>
         – ADEM (also known as postinfectious encephalitis) is a monophasic illness that is thought to be an autoimmune response to a preceding antigenic challenge (eg, a febrile illness or immunization) in genetically susceptible individuals [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6184.html" rel="external">
          "Acute disseminated encephalomyelitis (ADEM) in children: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis of ADEM should be suspected in a child who develops multifocal neurologic abnormalities with encephalopathy. Characteristic MRI findings of ADEM include multifocal white matter lesions; brainstem and spinal cord abnormalities are common. (See
         <a class="medical medical_review" href="/z/d/html/6184.html" rel="external">
          "Acute disseminated encephalomyelitis (ADEM) in children: Pathogenesis, clinical features, and diagnosis", section on 'Neuroimaging'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Anti-MOG antibodies can be identified in a large subset of patients with ADEM [
         <a href="#rid42">
          42
         </a>
         ]. Thus, all children with suspected ADEM should have testing performed to detect anti-MOG antibodies in the serum and CSF. (See
         <a class="medical medical_review" href="/z/d/html/6184.html" rel="external">
          "Acute disseminated encephalomyelitis (ADEM) in children: Pathogenesis, clinical features, and diagnosis", section on 'Serum autoantibodies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Toxic-metabolic encephalopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Encephalitis must be differentiated from encephalopathy caused by metabolic disorders, drugs, and toxins  (
         <a class="graphic graphic_table graphicRef68501" href="/z/d/graphic/68501.html" rel="external">
          table 4
         </a>
         and
         <a class="graphic graphic_table graphicRef71268" href="/z/d/graphic/71268.html" rel="external">
          table 12
         </a>
         ). These disorders can usually be distinguished from viral encephalitis by the lack of acute febrile illness, more gradual onset, lack of CSF pleocytosis, absence of focal changes on brain imaging, and presence (in some cases) of abnormal laboratory findings (eg, electrolyte abnormalities, hypoglycemia, acidosis, hyperammonemia, elevated blood lead level, positive toxicology tests). (See
         <a class="medical medical_review" href="/z/d/html/6154.html" rel="external">
          "Acute toxic-metabolic encephalopathy in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Intracranial pathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Brain abscess and other noninfectious intracranial pathology, such as tumor, intracranial hemorrhage, or thrombosis, usually can be differentiated from encephalitis through neuroimaging. (See
         <a class="medical medical_review" href="/z/d/html/6250.html" rel="external">
          "Clinical manifestations and diagnosis of central nervous system tumors in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6519.html" rel="external">
          "Intracranial epidural hematoma in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">
          "Cerebral venous thrombosis: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H668135483">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/109959.html" rel="external">
          "Society guideline links: Infectious encephalitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4112756968">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/17213.html" rel="external">
          "Patient education: Encephalitis (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Presentation
         </strong>
         – Encephalitis causes neurologic dysfunction and has a broad range of presenting symptoms and signs. Clinical manifestations may vary depending upon the patient's age and immune status, causative virus, and affected region(s) of the brain. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Neonates and young infants
         </strong>
         – In neonates and young infants, encephalitis can present with fever, seizure, poor feeding, irritability, or lethargy. Decreased perfusion may occur in infants with encephalitis and concomitant disseminated viral infection. Fever is a variable finding.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Children and adolescents
         </strong>
         – In older children and adolescents, encephalitis can present with fever, psychiatric symptoms, emotional lability, movement disorder, ataxia, seizures, stupor, lethargy, coma, or localized neurologic changes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
         – The evaluation of the child with suspected encephalitis begins with assessment of the airway, breathing, and circulation. The first priorities are stabilization of cardiorespiratory status and management of seizures  (
         <a class="graphic graphic_table graphicRef51779" href="/z/d/graphic/51779.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6393.html" rel="external">
          "Initial assessment and stabilization of children with respiratory or circulatory compromise"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6192.html" rel="external">
          "Management of convulsive status epilepticus in children", section on 'Emergency antiseizure treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         After the child is stabilized, the evaluation includes:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History and physical examination  (
         <a class="graphic graphic_table graphicRef57122" href="/z/d/graphic/57122.html" rel="external">
          table 5
         </a>
         and
         <a class="graphic graphic_table graphicRef73833" href="/z/d/graphic/73833.html" rel="external">
          table 6
         </a>
         and
         <a class="graphic graphic_table graphicRef71744" href="/z/d/graphic/71744.html" rel="external">
          table 7
         </a>
         ) (see
         <a class="local">
          'History'
         </a>
         above and
         <a class="local">
          'Physical examination'
         </a>
         above)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Initial laboratory tests  (
         <a class="graphic graphic_table graphicRef63632" href="/z/d/graphic/63632.html" rel="external">
          table 9
         </a>
         ) (see
         <a class="local">
          'Laboratory evaluation'
         </a>
         above)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neuroimaging (magnetic resonance imaging [MRI] is the modality of choice) (see
         <a class="local">
          'Neuroimaging'
         </a>
         above)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Electroencephalography (EEG) (see
         <a class="local">
          'Electroencephalogram'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The goals of the evaluation are to define the clinical syndrome (eg, acute encephalitis, postinfectious encephalitis, autoimmune encephalitis, meningitis, toxic or metabolic encephalopathy, etc) and to identify a specific etiology  (
         <a class="graphic graphic_table graphicRef62512" href="/z/d/graphic/62512.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_table graphicRef68501" href="/z/d/graphic/68501.html" rel="external">
          table 4
         </a>
         ). It is particularly important to consider etiologies that require specific therapy. (See
         <a class="local">
          'Overview'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical diagnosis
         </strong>
         – A clinical diagnosis of encephalitis can be made based on the following criteria (see
         <a class="local">
          'Diagnosis'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Altered mental status (ie, decreased or altered level of consciousness, lethargy, or personality change) lasting ≥24 hours with no alternative cause identified,
         <strong>
          plus
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ≥2 of the following for a "possible" diagnosis or ≥3 of the following for a "probable" diagnosis:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Documented fever ≥38°C (100.4°F) within 72 hours (before or after) presentation
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Generalized or partial seizures not fully attributable to preexisting seizure disorder
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         New-onset focal neurologic findings
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Cerebrospinal fluid (CSF) pleocytosis (≥5 white blood cells [WBCs]/microL)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Abnormality of brain parenchyma on neuroimaging suggestive of encephalitis that is new or appears to have acute onset
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Abnormality on EEG that is consistent with encephalitis and not attributable to another cause
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Identifying the pathogen
         </strong>
         – Testing for specific pathogens is directed by the clinical findings, initial laboratory findings, and other epidemiologic circumstances (eg, time of year, geographic locale, exposures). The causative pathogen may be identified through testing of the CSF (eg, polymerase chain reaction [PCR] and/or CSF immunoglobulin M [IgM] antibodies), serologic testing, and/or testing of anatomic sites other than the central nervous system (CNS; eg, respiratory tract, skin, stool). Identification of a pathogen known to cause encephalitis confirms the clinical diagnosis of viral encephalitis; however, in many cases, no specific etiology is identified. (See
         <a class="local">
          'Identifying the viral pathogen'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6043.html" rel="external">
          "Acute viral encephalitis in children: Pathogenesis, epidemiology, and etiology", section on 'Etiology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis of encephalitis is broad and includes other infections (eg, bacterial, mycobacterial, parasitic, fungal, and rickettsial), postinfectious or autoimmune encephalitis, toxic-metabolic encephalopathy, or other intracranial pathology (eg, abscess, tumor, hemorrhage)  (
         <a class="graphic graphic_table graphicRef68501" href="/z/d/graphic/68501.html" rel="external">
          table 4
         </a>
         ). The diagnostic considerations are narrowed through history, examination, laboratory evaluation, and neuroimaging. Autoimmune encephalitis is an increasingly identified noninfectious etiology. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/15759.html" rel="external">
          "Autoimmune (including paraneoplastic) encephalitis: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H316532855">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Paul Krogstad, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013; 57:1114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis 1998; 26:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Britton PN, Dale RC, Blyth CC, et al. Causes and Clinical Features of Childhood Encephalitis: A Multicenter, Prospective Cohort Study. Clin Infect Dis 2020; 70:2517.
          </a>
         </li>
         <li class="breakAll">
          Bronstein DE, Glaser CA. Encephalitis and meningoencephalitis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry J, Demmler-Harrison GJ, Steinbach WJ, Kaplan SL, Hotez PJ (Eds), Elsevier Saunders, Philadelphia 2019. p.361.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson C, Kneen R, Riordan A, et al. Encephalitis in children. Arch Dis Child 2012; 97:150.
          </a>
         </li>
         <li class="breakAll">
          Glaser C, Long SS. Encephalitis. In: Principles and Practice of Pediatric Infectious Diseases, 4th ed, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, Edinburgh 2012. p.297.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caviness AC, Demmler GJ, Selwyn BJ. Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study. Pediatr Infect Dis J 2008; 27:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fowler A, Stödberg T, Eriksson M, Wickström R. Childhood encephalitis in Sweden: etiology, clinical presentation and outcome. Eur J Paediatr Neurol 2008; 12:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galanakis E, Tzoufi M, Katragkou A, et al. A prospective multicenter study of childhood encephalitis in Greece. Pediatr Infect Dis J 2009; 28:740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43:1565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seiden JA, Zorc JJ, Hodinka RL, Shah SS. Lack of cerebrospinal fluid pleocytosis in young infants with enterovirus infections of the central nervous system. Pediatr Emerg Care 2010; 26:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharp J, Harrison CJ, Puckett K, et al. Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations. Pediatr Infect Dis J 2013; 32:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis 2002; 34:1154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jakob NJ, Lenhard T, Schnitzler P, et al. Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid. Crit Care Med 2012; 40:1304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balfour HH Jr, Siem RA, Bauer H, Quie PG. California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics 1973; 52:680.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Przelomski MM, O'Rourke E, Grady GF, et al. Eastern equine encephalitis in Massachusetts: a report of 16 cases, 1970-1984. Neurology 1988; 38:736.
          </a>
         </li>
         <li class="breakAll">
          Bronstein DE, Glaser CA. Encephalitis and meningoencephalitis. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 8th ed, Cherry J, Demmler-Harrison GJ, Steinbach WJ, Kaplan SL, Hotez PJ (Eds), Elsevier, 2019. p.361.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leber AL, Everhart K, Balada-Llasat JM, et al. Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens. J Clin Microbiol 2016; 54:2251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liesman RM, Strasburg AP, Heitman AK, et al. Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis. J Clin Microbiol 2018; 56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blaschke AJ, Holmberg KM, Daly JA, et al. Retrospective Evaluation of Infants Aged 1 to 60 Days with Residual Cerebrospinal Fluid (CSF) Tested Using the FilmArray Meningitis/Encephalitis (ME) Panel. J Clin Microbiol 2018; 56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramanan P, Bryson AL, Binnicker MJ, et al. Syndromic Panel-Based Testing in Clinical Microbiology. Clin Microbiol Rev 2018; 31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 2003; 36:731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med 2001; 344:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ward KN, Leong HN, Thiruchelvam AD, et al. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 2007; 45:1298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bykowski J, Kruk P, Gold JJ, et al. Acute pediatric encephalitis neuroimaging: single-institution series as part of the California encephalitis project. Pediatr Neurol 2015; 52:606.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maschke M, Kastrup O, Forsting M, Diener HC. Update on neuroimaging in infectious central nervous system disease. Curr Opin Neurol 2004; 17:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teixeira J, Zimmerman RA, Haselgrove JC, et al. Diffusion imaging in pediatric central nervous system infections. Neuroradiology 2001; 43:1031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okanishi T, Yamamoto H, Hosokawa T, et al. Diffusion-weighted MRI for early diagnosis of neonatal herpes simplex encephalitis. Brain Dev 2015; 37:423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lian ZY, Huang B, He SR, et al. Diffusion-weighted imaging in the diagnosis of enterovirus 71 encephalitis. Acta Radiol 2012; 53:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beattie GC, Glaser CA, Sheriff H, et al. Encephalitis with thalamic and basal ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses. Clin Infect Dis 2013; 56:825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           To TM, Soldatos A, Sheriff H, et al. Insights into pediatric herpes simplex encephalitis from a cohort of 21 children from the California Encephalitis Project, 1998-2011. Pediatr Infect Dis J 2014; 33:1287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baskin HJ, Hedlund G. Neuroimaging of herpesvirus infections in children. Pediatr Radiol 2007; 37:949.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parmar H, Ibrahim M. Pediatric intracranial infections. Neuroimaging Clin N Am 2012; 22:707.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gold JJ, Crawford JR, Glaser C, et al. The role of continuous electroencephalography in childhood encephalitis. Pediatr Neurol 2014; 50:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pillai SC, Hacohen Y, Tantsis E, et al. Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome. Pediatrics 2015; 135:e974.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lai CW, Gragasin ME. Electroencephalography in herpes simplex encephalitis. J Clin Neurophysiol 1988; 5:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suleiman J, Brenner T, Gill D, et al. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 2011; 76:1252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bseikri MR, Barton JR, Kulhanjian JA, et al. Anti-N-methyl D-aspartate receptor encephalitis mimics viral encephalitis. Pediatr Infect Dis J 2012; 31:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54:899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salama S, Khan M, Pardo S, et al. MOG antibody-associated encephalomyelitis/encephalitis. Mult Scler 2019; 25:1427.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6042 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23861361" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9502462" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31549170" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Causes and Clinical Features of Childhood Encephalitis: A Multicenter, Prospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31549170" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Causes and Clinical Features of Childhood Encephalitis: A Multicenter, Prospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21715390" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Encephalitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21715390" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Encephalitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18582201" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18360301" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18313340" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Childhood encephalitis in Sweden: etiology, clinical presentation and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19633519" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : A prospective multicenter study of childhood encephalitis in Greece.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17109290" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Beyond viruses: clinical profiles and etiologies associated with encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20093996" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Lack of cerebrospinal fluid pleocytosis in young infants with enterovirus infections of the central nervous system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23042051" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11915008" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22067626" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4355363" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3362371" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Eastern equine encephalitis in Massachusetts: a report of 16 cases, 1970-1984.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3362371" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Eastern equine encephalitis in Massachusetts: a report of 16 cases, 1970-1984.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27335149" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29436421" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29669791" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Retrospective Evaluation of Infants Aged 1 to 60 Days with Residual Cerebrospinal Fluid (CSF) Tested Using the FilmArray Meningitis/Encephalitis (ME) Panel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29142077" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Syndromic Panel-Based Testing in Clinical Microbiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12627357" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11248155" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : La Crosse encephalitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17229866" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25846458" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Acute pediatric encephalitis neuroimaging: single-institution series as part of the California encephalitis project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15247545" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Update on neuroimaging in infectious central nervous system disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11792040" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Diffusion imaging in pediatric central nervous system infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25149136" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Diffusion-weighted MRI for early diagnosis of neonatal herpes simplex encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22184685" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Diffusion-weighted imaging in the diagnosis of enterovirus 71 encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23196954" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Encephalitis with thalamic and basal ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24911898" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Insights into pediatric herpes simplex encephalitis from a cohort of 21 children from the California Encephalitis Project, 1998-2011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17572889" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Neuroimaging of herpesvirus infections in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23122263" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Pediatric intracranial infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24507696" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The role of continuous electroencephalography in childhood encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25802349" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3150762" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Electroencephalography in herpes simplex encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19670433" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21464429" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : VGKC antibodies in pediatric encephalitis presenting with status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22094630" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Anti-N-methyl D-aspartate receptor encephalitis mimics viral encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22281844" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30907249" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : MOG antibody-associated encephalomyelitis/encephalitis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
